Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. - Wikidata - wikimedia - TriplyDB

Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension.

Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension.

http://www.wikidata.org/entity/Q44392830

about

The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men Adverse events associated with testosterone administration Testosterone for the aging male; current evidence and recommended practice Discovery and therapeutic promise of selective androgen receptor modulators Do fat supplements increase physical performance?Influence of androgens on circulating adiponectin in male and female rodents Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.Treatment with oxandrolone and the durability of effects in older men.Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss.Sildenafil increases muscle protein synthesis and reduces muscle fatigue.Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study Selective androgen receptor modulators as function promoting therapies.Drug abuse in athletes.Effects of long term supplementation of anabolic androgen steroids on human skeletal muscle.Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice.Out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes Why is muscularity sexy? Tests of the fitness indicator hypothesis.Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.Endocrinology of the aging male.Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation.Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation Testosterone metabolism, dose-response relationships and receptor polymorphisms: selected pharmacological/toxicological considerations on benefits versus risks of testosterone therapy in men.Testosterone and sport: current perspectives.DESIGNING DRUG TRIALS FOR SARCOPENIA IN OLDER ADULTS WITH HIP FRACTURE - A TASK FORCE FROM THE INTERNATIONAL CONFERENCE ONFRAILTY AND SARCOPENIA RESEARCH (ICFSR).Pulmonary rehabilitation in chronic obstructive pulmonary disease.Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging Advances in male hormone substitution therapy.National Athletic Trainers' Association position statement: anabolic-androgenic steroids.Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial.Indirect androgen doping by oestrogen blockade in sports.Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men.The significance of testosterone for fair participation of the female sex in competitive sports Testosterone treatment of hypogonadal men participating in competitive sports.An exploration of the association between frailty and muscle fatigue.Enhanced muscle fatigue occurs in male but not female ASIC3-/- mice.Effect of nandrolone decanoate administration on recovery from bupivacaine-induced muscle injury.Association between testosterone and estradiol and age-related decline in physical function in a diverse sample of men Androgen effects on skeletal muscle: implications for the development and management of frailty.

P2860

Q24561868-22376E42-EE72-4A97-A3FE-1B2936F34F37 Q24601802-5900F316-E9BB-4E80-ABDA-6C549F2AC45F Q24647679-522B7BD2-53E5-407C-A8CF-98BC27150D37 Q24680356-05A7E879-4CF8-43AA-8BF2-72E065DEC6AF Q26825805-B3C259AE-B4E3-4550-84F2-049CB6E15188 Q27314775-4C0FB403-8C4E-4E94-9778-875ABAA443A6 Q28391291-3A895C79-A312-4AFE-9F1B-D81149B89032 Q30409171-B462335D-6D61-4940-8D1F-1E783797B413 Q30882835-4FAC4657-434A-4DAB-8B6A-4BE5E351FF46 Q33330243-A9C770E4-8B6F-45F3-86E1-9E6ECBE77C74 Q33827719-8C00E9BD-E507-4EAA-8715-B6C289F9311C Q33984860-E06B5B78-3417-456B-956C-F27E6030CCFD Q34007493-5CCF1745-54D6-4493-9E0A-7DFB3A04EF97 Q34075256-E17EE5A6-8A49-49AC-9FE8-DEE140623356 Q34160098-71CD5B16-14AA-4D30-979E-1B4804C1E04A Q34203697-8870ED7C-492A-47F5-9DD5-E14B58994629 Q34273954-0BB4406E-DA0E-4310-A884-9EFC38E39FA4 Q34281138-25952231-7F96-4C46-8302-A22CC9CA080D Q34639293-CB669C8C-90DC-49CB-88CC-80DDD081AB48 Q34697114-4E82D4D1-B063-4E35-8ABF-A969E372DCD7 Q34777308-1F5B7513-23EB-43F7-B81A-FF0F2C43ECC6 Q35036928-3580A40F-BB50-407F-AE12-695C1768F6CF Q35459531-C7F62B74-4B00-44C1-AF07-B049F5CC2C4D Q35684578-9CA00454-FE2D-4CDF-992F-1BD815EB21B6 Q35690905-878A5303-54B1-42BB-95C3-D64AD3D7815A Q36057081-4529A518-18F5-4A5D-BC3E-5403BB1BEEC7 Q36075213-22837FF2-B1E6-4E90-98CA-51429CBD34A3 Q36130944-FA4684FC-8E61-4741-83F4-6B5B513D5F31 Q36221968-C40C2E78-D21B-46C1-9D7C-B4DD6D2258A3 Q36299949-4FCA7B9A-8D91-42BC-8749-A08BBA30B429 Q36430047-1A2A190A-454E-4704-8AC5-E8631CC9BFB8 Q36736110-BD75E994-0C84-44B8-AE84-01380373023C Q36978134-7C879D68-BF7A-47B7-B851-77EE9C68A7CA Q37085281-F2303BF6-5E1B-4D06-BC7C-280551E9F2C3 Q37162673-A4FA68A7-FDBA-4C21-BB2A-012E1D494C1C Q37222255-C425DA73-FF9B-442F-9191-AF2BE3D9E063 Q37352915-9F0E6182-235E-483D-8B01-7F85B11AA013 Q37422180-B547B62F-5BA9-4921-9F81-4CF264C11FEB Q37453660-4BDBF6C1-9C1B-4465-A90F-DABA7F2B4FD1 Q37639192-BF4F391A-020E-4037-8CDC-C37392E9B14C

P2860

Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension.

http://www.wikidata.org/entity/Q44392830

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Testosterone dose-dependently ...... igability or specific tension.

@en

Testosterone dose-dependently ...... igability or specific tension.

@nl

type

label

Testosterone dose-dependently ...... igability or specific tension.

@en

Testosterone dose-dependently ...... igability or specific tension.

@nl

prefLabel

Testosterone dose-dependently ...... igability or specific tension.

@en

Testosterone dose-dependently ...... igability or specific tension.

@nl

P1433

Q44392830-51632BFB-41BD-4541-AF90-ACA613A21E66

P1476

Q44392830-E581C949-B30C-4C83-A0CF-73E0CC5C9A64

P2093

Q44392830-38D91E87-9E0B-4459-8CC1-D032DF582320

Q44392830-42D795CF-AF62-4A84-A869-0547996608BB

Q44392830-7ABE70D8-2C32-448C-8382-891448F7D15C

Q44392830-B526B94A-8846-42EE-B98E-8847804E1C8F

Q44392830-CE8F540E-23F3-41D1-9B65-3B4DFE2DA333

Q44392830-E62E9A89-CB76-485A-8498-D4C5B19E1207

Q44392830-F1344386-DDB9-460A-89A1-62B43FF101E9

P304

Q44392830-347401C5-A059-4819-B248-0EE6A9A52032

P31

Q44392830-43CEF78D-3F7D-470C-B081-535D49B81F80

P356

Q44392830-A270C174-F94E-4859-AF6F-B94254235D56

P407

Q44392830-E8A9E6ED-5C0C-4CAE-8B2B-56E50732A885

P433

Q44392830-6E08A037-3C61-467B-A2C1-659A0123A37A

P478

Q44392830-CB22A206-3159-499A-A787-2B76B606B703

P50

Q44392830-F2A90D3D-3914-49D9-BEC2-1B915EC47332

P577

Q44392830-A33D0699-AE1C-450B-8FD3-DC6BF18D8C9C

P5875

Q44392830-36039F02-CD28-431E-976F-D1E02322EC55

P698

Q44392830-8D37B185-D5F2-46C3-BB44-6DC6B12AAF62

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Testosterone dose-dependently ...... igability or specific tension.

@en

P2093

Connie Dzekov

http://www.w3.org/2001/XMLSchema#string

Jeanne Dzekov

http://www.w3.org/2001/XMLSchema#string

Linda Woodhouse

http://www.w3.org/2001/XMLSchema#string

Lynne Magliano

http://www.w3.org/2001/XMLSchema#string

Martin L Lee

http://www.w3.org/2001/XMLSchema#string

Richard Casaburi

http://www.w3.org/2001/XMLSchema#string

Thomas W Storer

http://www.w3.org/2001/XMLSchema#string

P304

1478-1485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2002-021231

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Shalender Bhasin

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10819416

http://www.w3.org/2001/XMLSchema#string

P698

12679426

http://www.w3.org/2001/XMLSchema#string